Aalto University has signed a new agreement with Spain’s ESADE Business School. The two institutions will expand their offering of training, leadership development and support for entrepreneurs and executives dedicated to innovating through design and technology as a means of creating new business opportunities.

More efficient medical treatments could be developed thanks to a new method for triggering the rearrangement of chemical particles.

While other social media networks for researchers are about showing off publications or keeping tabs on impact metrics, Piirus makes introductions. This is the way to find your perfect partner – for research, says Piirus founder Fiona Colligan

The President of Singapore today laid foundation stones to mark the development of two buildings for the Lee Kong Chian School of Medicine.

The MED-EU strategic project aims to raise EU funds for scientific research and innovation. The project is coordinated by the University of Bologna and a few clinical institutes such as the S.Orsola-Malpighi University Hospital, the Rizzoli Institute for Orthopedics and the Institute for Neurologic Sciences of the Bellaria hospital.

Dr. Gilbert Lenssen, ABIS' Founding President: "I am confident that Sauquet will lead the network with great strength and support from its members"

Fluidic Analytics Limited, a spinout from the University of Cambridge, has raised £1.56 million (US$2.4 million) in a Series A financing led by Cambridge Enterprise and including DFJ Esprit, IQ Capital, Parkwalk Advisors and Amadeus Capital Partners as co-investors.

ESADE will develop educational offerings specifically designed to strengthen the executive and leadership skills of digital entrepreneurs

A new drug for ovarian cancer, developed by researchers at the University of Cambridge and AstraZeneca, has become the first of new class of drugs, known as PARP-inhibitors, to be granted approval anywhere in the world. The drug, Lynparza, has been granted Marketing Authorisation from the European Commission.